Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients

By Massicotte P.   Julian J.A.   Marzinotto V.   Gent M.   Shields K.   Chan A.K.   Szechtman B.   Kohne S.   Shepherd S.   Bacher P.   Andrew M.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

“Bridging” Therapy with Low Molecular Weight Heparin in Pregnant Patients and Patients with Mechanical Prosthetic Heart Valves

By Groce III James B.  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 1-2, 2003-08 ,pp. : 79-82

Springer Publishing Company

Access to resources Recommend Favorite

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin

By Lim A.Y.H.   Parr D.G.   Stableforth D.E.   Fellows M.   Fontaine R.   Fegan C.D.  

European Journal of Internal Medicine, Vol. 14, Iss. 2, 2003-03 ,pp. : 89-93

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy

By Pross M.   Lippert H.   Misselwitz F.   Nestler G.   Kruger S.   Langer H.   Halangk W.   Schulz H.-U.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome

By Di Simone N   Caliandro D   Castellani R   Ferrazzani S   De Carolis S   Caruso A  

Human Reproduction, Vol. 14, Iss. 2, 1999-02 ,pp. : 489-495

Oxford University Press

Access to resources Recommend Favorite